[1] 郑雯娜,章锦曼,朱宝生.小剂量阿司匹林预防子痫前期的研究进展[J].中国妇幼保健,2015,30(21):3754-3758. [2] ATALLAH A,LECARPENTIER E,GOFFINET F, et al.Aspirin for Prevention of Preeclampsia[J].Drugs,2017,77(17):1819-1831. [3] XU T, ZHOU F, DENG C, et al.Low-dose aspirin for preventing preeclampsia and its complication:A Meta-Analysis[J]. J Clinc Hypertens,2015,17(7):567-573. [4] 郭惠萍,沈丽丹.孕早期小剂量阿司匹林干预对预防子痫前期的意义[J].临床和实验医学杂志,2019,18(3):287-290. [5] 王伟.小剂量阿司匹林治疗子痫前期高危孕妇的临床效果研究[J].实用妇科内分泌杂志(电子版),2018,5(29):83-85. [6] WHO. Recommendations for prevention and treatment of pre-eclampsia and eclampsia[M]. Geneva:World Health Organization, 2011. [7] HENDERSON J T,WHITLOCK E P, O'CONNOR E, et al. Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia:A systematic evidence review for the U S Preventive Services Task Force[J].Ann Inten Med,2014,160(10):695-703. [8] 芮璨,宋学静,陆元庆,等.妊娠20周后应用小剂量阿司匹林预防子痫前期的疗效分析[J]. 实用妇产科杂志,2016,32(12):913-916. [9] ROLNIK DL,WRIGHT D,POON LC,et al.Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med,2017,377(7):613-622. [10] JOSEPH L S,JOSEPH K S.Incidence of preeclampsia:risk factors and outcomes associated with early-versus late-onset disease[J].Am J Obstet Gynecol,2013,209(6):544.e1-544.e12. [11] 殷茵,孙丽洲.子痫前期凝血状态评估及抗凝治疗[J]. 实用妇产科杂志,2014,30(11):803-805. [12] MEHER S,DULEY L,HUNTER K,et al.Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia:An individual participant data meta-analysis[J]. Am J Obstet Gynecol,2017,216(2):121-128.e2 [13] 殷茵,孙丽洲.120例早发型子痫前期孕妇解痉抗凝治疗的临床分析[J].实用妇产科杂志,2012,28(2):115-118. [14] 李玉霞.低剂量阿司匹林预防高危孕妇子痫前期疗效及安全性分析[J].淮海医药,2016,34(2):169-171. [15] 罗丽丽.小剂量阿司匹林在子痫前期高危人群中的预防价值[J].中国实用医药,2015,10(20):142-143. [16] SULTAN P, BUTWICK A. Platelet counts and coagulation tests prior to neuraxial anesthesia in patients with preeclampsia:A retrospective analysis[J].Clin Appl Thromb Hemost,2013,19(5):529-534. [17] EMONTS P, SEAKSAN S, SEIDEL L et al.Prediction of maternal predisposition to preeclampsia[J].Hypertens Pregnancy,2008,27(3):237-245. [18] 蒋励帅.子痫前期患者凝血功能、血小板参数与血脂指标变化的探讨[D].乌鲁木齐:新疆医科大学,2013. [19] KOBAYASHI T, TOKUNAGA N, SUGIMURA M. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia[J]. Semin Thromb Hemost,2009,31(2):227-232. [20] MARIETTA M,SIMONI L,PEDRAZZI P, et al. Antithrombin plasma levels decrease is associated with preeclampsia worsening[J].Int J Lab Hemato1,2008,16(4):457-459. [21] 胡进霞,田凤梅.子痫前期患者凝血指标的监测及其临床意义[J].宁夏医学杂志,2012,34(3):236-237. [22] 李可,朱大伟,陈建昆,等.子痫前期发病机制与临床治疗研究进展[J].解放军医学杂志,2019,44(5):423-429. [23] 欧阳艳琼.氧化应激和炎症反应在子病前期中的作用及其相互关系的研究[D].上海:华中科技大学,2007. [24] 罗欣,漆洪波.子痫前期发病机制分子生物学研究进展[J].中国实用妇科与产科杂志,2012,28(4):309-311. [25] KIM J, LEE KS,KIM JH, et al. Aspirin prevents TNF-α-induced the endothelial cell dysfunction by regulating the NF-κB-dependent miR-155/eNOS pathway:Role of a miR-155/eNOS axis in preeclampsia[J]. Free Radic Biol Med,2017,104:185-198. [26] 岳永飞,许多.P选择素与子痫前期关系的研究进展[J].国际妇产科学杂志,2014,41(2):167-170. [27] MOL BW, ROBERTS CT, THANGARATINAM S, et al. Pree-eclampsia[J]. Lancet, 2016, 387(10022):999-1011. [28] REDMAN CW.Hypertension in pregnancy:The NICE guidelines[J]. Heart, 2011,97(2):1967-1969. [29] GRANDONE E,VILLANI M,TISCIA CL.Aspprin and heparin in pregnancy[J].Expert Opin Pharmacother, 2015,16(12):1793-1803. [30] 马晓彬. 低剂量阿司匹林预防高危孕妇子病前期的临床价值[J]. 中国医药指南,2019, 17(7):79-80. [31] 王春雨,王海鹏,刘洁.脑梗死患者应用阿司匹林联合他汀类药物对颈动脉斑块的影响评价[J].中国实验诊断学,2014,18(7):1087-1089. |